Skye Bioscience Files Definitive Proxy Statement
Ticker: SKYE · Form: DEF 14A · Filed: Sep 23, 2024 · CIK: 1516551
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-meeting
Related Tickers: SKYE
TL;DR
Skye Bioscience (SKYE) filed its DEF 14A proxy statement - shareholders vote soon on company matters.
AI Summary
Skye Bioscience, Inc. filed a Definitive Proxy Statement (DEF 14A) on September 23, 2024. This filing provides information to shareholders regarding the company's annual meeting and voting matters. The company, formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is crucial for shareholders as it outlines the proposals they will vote on at the company's annual meeting, impacting corporate governance and future strategic decisions.
Risk Assessment
Risk Level: low — A DEF 14A filing is a standard regulatory document and does not inherently represent a change in the company's risk profile.
Key Players & Entities
- Skye Bioscience, Inc. (company) — Registrant
- Emerald Bioscience, Inc. (company) — Former Company Name
- Nemus Bioscience, Inc. (company) — Former Company Name
- 20240923 (date) — Filing Date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings, providing detailed information on matters to be voted upon.
When was this DEF 14A filing submitted by Skye Bioscience, Inc.?
The DEF 14A filing by Skye Bioscience, Inc. was submitted on September 23, 2024.
What were some previous names of Skye Bioscience, Inc.?
Skye Bioscience, Inc. was formerly known as Emerald Bioscience, Inc. and Nemus Bioscience, Inc.
In which state is Skye Bioscience, Inc. incorporated?
Skye Bioscience, Inc. is incorporated in Nevada (NV).
What is the primary business sector for Skye Bioscience, Inc.?
Skye Bioscience, Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
Filing Stats: 4,878 words · 20 min read · ~16 pages · Grade level 12.5 · Accepted 2024-09-23 17:25:23
Filing Documents
- skyebioscience-definitivep.htm (DEF 14A) — 591KB
- chart-6bc659332af649b6828.jpg (GRAPHIC) — 128KB
- chart-9481c9bd40514f548a1.jpg (GRAPHIC) — 139KB
- picture1.jpg (GRAPHIC) — 5KB
- screenshot2024-09x23085208a.jpg (GRAPHIC) — 116KB
- screenshot2024-09x23085556a.jpg (GRAPHIC) — 117KB
- 0001516551-24-000089.txt ( ) — 1287KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 22
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 24 DIRECTOR COMPENSATION 28 PAY VERSUS PERFORMANCE 30 HOUSEHOLDING OF PROXY MATERIALS 34 STOCKHOLDER PROPOSALS 34 ADJOURNMENT OF THE SPECIAL MEETING OF SHAREHOLDERS 35 WHERE YOU CAN FIND MORE INFORMATION 35 APPENDIX A 36 PROXY CARD 53 3 TABLE OF CONTENTS SKYE BIOSCIENCE, INC. 11250 El Camino Real, Suite 100 San Diego, CA 92130 (858) 410-0266 PROXY STATEMENT FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON TUESDAY, OCTOBER 22, 2024 The Board of Directors of Skye Bioscience, Inc. is soliciting the enclosed proxy for use at the Special Meeting of stockholders to be held on Tuesday, October 22, 2024 at 1000 a.m., Pacific Time. The Special Meeting will be a virtual meeting, which will be conducted via live webcast. Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be held on Tuesday, October 22, 2024 This proxy statement ("Proxy Statement") is available electronically at www.virtualshareholdermeeting.comSKYE2024SM . QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING Why am I receiving these materials We have sent you these proxy materials because our Board of Directors (the "Board") is soliciting your proxy to vote at a Special Meeting of stockholders (the "Special Meeting") of Skye Bioscience, Inc., a Nevada corporation ("we," "us," the "Company" or "Skye") to be held virtually, via live webcast at www.virtualshareholdermeeting.comSKYE2024SM, on Tuesday, October 22, 2024, at 1000 a.m. Pacific Time, and any adjournment or postponement thereof. You are invited to attend the virtual Special Meeting to vote on the proposal described in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, date, sign and return the enclosed proxy card, or follow the instructions below to vote over the telephone or through the internet. Stockholders attending the virtual Special Meeting will be affor